Relationship between Heart Disease and Liver Disease: A Two-Way Street

Hamza El Hadi1,2, Angelo Di Vincenzo1, Roberto Vettor1

  • 1Internal Medicine 3, Department of Medicine - DIMED, University of Padova, Via Giustiniani2, 35100 Padova, Italy.

Cells
|March 4, 2020
PubMed

Insights

This review explores the intricate cardio-hepatic interactions in heart and liver diseases. Understanding these links is vital for improving patient outcomes and treatment strategies for both conditions.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Combined heart and liver dysfunctions are common due to complex cardio-hepatic interactions.
  • Effective management of patients with heart or liver disease necessitates understanding these inter-organ relationships.
  • Identifying cardio-hepatic crosstalk is crucial for improving patient prognosis and therapeutic efficacy.

Purpose of the Study:

  • To review the complex crosstalk between the heart and liver in major pathological conditions affecting these organs.
  • To summarize clinical, biochemical, and histological findings related to cardio-hepatic interactions.
  • To discuss cardiac dysfunction in liver cirrhosis, nonalcoholic fatty liver disease, and post-liver transplantation.

Main Methods:

  • Literature review of studies on cardio-hepatic interactions.
  • Synthesis of clinical manifestations, biochemical profiles, and histological findings.
  • Discussion of cardiac dysfunction in various liver diseases.

Main Results:

  • Cardiogenic ischemic hepatitis and congestive hepatopathy are key manifestations of heart failure impacting the liver.
  • Cardiac dysfunction is a significant feature in liver cirrhosis and nonalcoholic fatty liver disease.
  • Liver transplantation can lead to specific cardiac complications.

Conclusions:

  • Understanding cardio-hepatic interactions is essential for managing patients with coexisting heart and liver diseases.
  • This review provides a comprehensive overview of the clinical and pathological aspects of cardio-hepatic crosstalk.
  • Further research into these interactions can lead to improved therapeutic strategies and patient outcomes.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
167
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
130
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
614
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
538